| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/10/1996 | EP0720855A2 Composition for the treatment of hypertension comprising non halide salts of potassium |
| 07/10/1996 | EP0720854A1 Use of bile acids for the preparation of a medicament for the treatment of skin disorders |
| 07/10/1996 | EP0720853A1 Topical administrable zinc phtalocyanine compositions |
| 07/10/1996 | EP0720852A1 Remedy for nervous diseases |
| 07/10/1996 | EP0720850A1 Method for the diagnosis of a dysfunction of 5-HT 1A receptors |
| 07/10/1996 | EP0720849A2 Agents for inhibiting the production of IL-1beta and the release of TNFalpha |
| 07/10/1996 | EP0720848A1 Use of tamarind seed extracts enriched in xyloglycans and cosmetics or pharmaceuticals containing them |
| 07/10/1996 | EP0720847A1 Cosmetic or dermatological composition containing at least one ceramide 6 |
| 07/10/1996 | EP0720652A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 07/10/1996 | EP0720635A1 Phthalocyanine photosensitizers for photodynamic therapy and methods for their synthesis and use |
| 07/10/1996 | EP0720620A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 07/10/1996 | EP0720617A1 Novel urethane-containing aminosteroid compounds |
| 07/10/1996 | EP0720616A1 Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
| 07/10/1996 | EP0720612A1 Novel substituted propane-2-ol derivatives |
| 07/10/1996 | EP0720610A1 Phorbine derivatives and their use in the diagnosis and therapy of cancer |
| 07/10/1996 | EP0720609A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins |
| 07/10/1996 | EP0720607A1 Substituted tetronic acids useful for treating hiv and other retroviruses |
| 07/10/1996 | EP0720604A1 Conformationally locked nucleoside analogues |
| 07/10/1996 | EP0720603A1 Bis(amidinobenzimidazolyl)alkanes as antiviral agents |
| 07/10/1996 | EP0720601A1 Gastrin and cck receptor ligands |
| 07/10/1996 | EP0720600A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases |
| 07/10/1996 | EP0720599A1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 07/10/1996 | EP0720598A1 Phenoxyphenyl cyclopentenyl hydroxyureas |
| 07/10/1996 | EP0720597A1 Triaryl-ethylene derivatives for use in therapy |
| 07/10/1996 | EP0720551A1 Hydraulic system for anti-lock braking installations in motor vehicles |
| 07/10/1996 | EP0720481A1 Uses of vegetable oils |
| 07/10/1996 | EP0720480A1 Enteric coated oral compositions containing bisphosphonic acid derivatives |
| 07/10/1996 | EP0720479A1 Transdermal therapeutic system with acetylsalicylic acid as active substance |
| 07/10/1996 | EP0720478A1 A controlled, sustained release delivery system for smoking cessation |
| 07/10/1996 | EP0720477A1 Method and compositions for maintaining glomerular filtration rate while inhibition extracellular matrix accumulation |
| 07/10/1996 | EP0720476A1 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/$g(b)-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE |
| 07/10/1996 | EP0720475A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease |
| 07/10/1996 | EP0720474A1 Volatile active substance containing plaster that may be produced without solvents |
| 07/10/1996 | EP0720473A1 Budesonide pellets with a controlled release pattern and process for producing them |
| 07/10/1996 | EP0666929A4 Method of inhibiting replication of hyperproliferative cells. |
| 07/10/1996 | EP0635012B1 Unbridged bis-aryl carbinol derivatives, compositions and methods of use |
| 07/10/1996 | EP0626855A4 Health and beauty aid compositions. |
| 07/10/1996 | EP0619818B1 Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring |
| 07/10/1996 | EP0556240B1 Chelating agents |
| 07/10/1996 | EP0457888B1 Octapeptide analogs of somatostatin having threonine at the sixth position |
| 07/10/1996 | CN1126491A Intracellular binding proteins and use thereof |
| 07/10/1996 | CN1126473A Carbazole derivatives with 17,20-lyase-inhibiting activity |
| 07/10/1996 | CN1126472A 5-HT4 receptor antagonists |
| 07/10/1996 | CN1126471A Tetrazole derivatives having antihistaminic and antiallergic activity |
| 07/10/1996 | CN1126470A Pyridazinone derivatives with pharmaceutical activity |
| 07/10/1996 | CN1126469A HIV protease inhibitors useful for the treatment of aids |
| 07/10/1996 | CN1126468A Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 07/10/1996 | CN1126466A Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 07/10/1996 | CN1126441A Amplification of the vitamin B12 uptake system using polymers |
| 07/10/1996 | CN1126438A Method of combating acyclovir-resistant herpes simplex viral infections |
| 07/10/1996 | CN1126436A Vitamin B12 mediated oral delivery systems for GCSF and EPO |
| 07/10/1996 | CN1126435A Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 07/10/1996 | CN1126434A Therapeutic substituted guanidines |
| 07/10/1996 | CN1126432A Oral compositions for treating plaque and gingivitis containing a noncationic antibacterial agent and a bicarbonate salt |
| 07/10/1996 | CN1126212A Camptothecin derivatives, preparations thereof and antitumor agents |
| 07/10/1996 | CN1126211A Quinolone- and naphthyridonecarboxylic acid derivatives |
| 07/10/1996 | CN1126207A Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
| 07/10/1996 | CN1126203A Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 07/10/1996 | CN1126202A Heterocyclyloxy benzoylguanidin |
| 07/10/1996 | CN1126201A Fullfluoralkyl-substituted bezoylguanidine, preparation, parmaceuticle use of same and pharmaceutical containing same |
| 07/10/1996 | CN1126198A Substituted cyclohexanolester, disease treatment application and pharmaceutical agent of same |
| 07/10/1996 | CN1126073A Compound cinrofloxacin ear drop |
| 07/10/1996 | CN1126072A Ophthalmic preparations for reducing intraocular pressure |
| 07/10/1996 | CN1126030A Processing technique of hydrophilic prepn. of albendazole |
| 07/10/1996 | CN1032258C Process for preparacing phospholpid derivatives of nucleosides |
| 07/10/1996 | CN1032257C Process for preparing pyrroliaylthio-carbapenem derivatives |
| 07/10/1996 | CN1032256C Method for preparation and use of 1 alpha, 24 dihydroxy vitamin D2 |
| 07/10/1996 | CN1032255C 1 alpha-hydroxy vitamin D4 and intermediates and analogues |
| 07/10/1996 | CN1032253C Process for preparation of oxalylamino acid derivatives, and their use as medicaments for inhibiting proline hydroxylase |
| 07/10/1996 | CN1032236C Process for preparing liposomes that provide thymic dependent help to weak vaccine antigens |
| 07/10/1996 | CN1032235C Method for producing kedarcidine antitumor chromophore |
| 07/09/1996 | US5534644 Process for the preparation of 4-methyl-5-(2-chloroethyl)-thiazole and analogues thereof |
| 07/09/1996 | US5534640 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds |
| 07/09/1996 | US5534636 Antiinflammatory agents, antitumor agent, cognition activators,bactericides, and fungicides |
| 07/09/1996 | US5534625 Melamine derivatives for use in the treatment of cancer |
| 07/09/1996 | US5534554 Antiinflammatory, viricide, effective against herpes, aids |
| 07/09/1996 | US5534553 Drug containing fatty amino alcohols or derivatives thereof |
| 07/09/1996 | US5534551 Production of powder which can be compressed into a tablet |
| 07/09/1996 | US5534549 Easters of acyl L-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma |
| 07/09/1996 | US5534548 Method of treating preeclampsia |
| 07/09/1996 | US5534547 Prostaglandins of the D series, and tranquilizers and soporifics containing the same |
| 07/09/1996 | US5534545 Parenteral amino acid formulations for the inhibition of systemic hypotension associated with nitric oxide production |
| 07/09/1996 | US5534544 Surfactants and emulsifying agents to inhibit Helicobacter |
| 07/09/1996 | US5534540 Crosslinking and discoloration inhibition; preserving foods; aging resistance |
| 07/09/1996 | US5534539 Antitumor agents |
| 07/09/1996 | US5534535 Antiviral analogs with substituted benzimidazole base |
| 07/09/1996 | US5534534 Pharmaceutical compositions for oral use and method of preparing them |
| 07/09/1996 | US5534533 Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity |
| 07/09/1996 | US5534531 Anticancer agents |
| 07/09/1996 | US5534530 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them |
| 07/09/1996 | US5534529 Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 07/09/1996 | US5534528 Thiadiazolyl tetrhydrpyridines for treating glaucoma |
| 07/09/1996 | US5534527 Treatment of osteoporosis |
| 07/09/1996 | US5534526 Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome |
| 07/09/1996 | US5534525 Lactam derivatives |
| 07/09/1996 | US5534524 Suppression of bone resorption by quinolines |
| 07/09/1996 | US5534523 Anti-aids virus composition |
| 07/09/1996 | US5534522 (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent |
| 07/09/1996 | US5534520 Spiro compounds containing five-membered rings |
| 07/09/1996 | US5534519 5,10,-methylene-tetrahydrofolate as a modulator of a chemotherapeutic agent |